APGE - CIK 0001974640
Apogee Therapeutics, Inc. has filed 262 documents with the SEC between 2023 and 2026. The most frequent type is insider trade (88 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Major company event | 8-K | 2025-05-12 | 2025-05-12 |
| Quarterly report | 10-Q | 2025-05-12 | 2025-03-31 |
| SCHEDULE 13G/A | - | 2025-05-12 | - |
| Insider trade | 4 | 2025-05-09 | 2025-05-07 |
| Annual report to shareholders | ARS | 2025-04-29 | 2024-12-31 |
| Proxy materials | DEFA14A | 2025-04-29 | - |
| Proxy statement | DEF 14A | 2025-04-29 | 2025-06-17 |
| Insider trade | 4 | 2025-04-04 | 2025-04-02 |
| Insider sale notice | 144 | 2025-04-02 | - |
| Major company event | 8-K | 2025-03-11 | 2025-03-10 |
| Insider trade | 4 | 2025-03-07 | 2025-03-05 |
| Insider trade | 4 | 2025-03-07 | 2025-03-05 |
| Insider sale notice | 144 | 2025-03-05 | - |
| Major company event | 8-K | 2025-03-03 | 2025-03-03 |
| Employee stock plan | S-8 | 2025-03-03 | - |
| Annual report | 10-K | 2025-03-03 | 2024-12-31 |
| SCHEDULE 13G | - | 2025-02-14 | - |
| Insider trade | 4 | 2025-02-07 | 2025-02-05 |
| Insider trade | 4 | 2025-02-07 | 2025-02-05 |
| Insider sale notice | 144 | 2025-02-05 | - |
| Major company event | 8-K | 2025-02-03 | 2025-02-03 |
| Insider trade | 4 | 2025-01-31 | 2025-01-31 |
| Insider trade | 4 | 2025-01-10 | 2025-01-08 |
| Insider sale notice | 144 | 2025-01-08 | - |
| Insider trade | 4 | 2025-01-03 | 2025-01-02 |
| Insider trade | 4 | 2024-12-16 | 2024-12-12 |
| Insider trade | 4 | 2024-12-13 | 2024-12-11 |
| Insider sale notice | 144 | 2024-12-11 | - |
| Insider trade | 4 | 2024-12-11 | 2024-12-09 |
| Insider trade | 4 | 2024-12-11 | 2024-12-09 |
| Insider trade | 4 | 2024-12-11 | 2024-12-09 |
| Major company event | 8-K | 2024-12-10 | 2024-12-10 |
| Insider trade | 4 | 2024-12-06 | 2024-12-04 |
| Insider trade | 4 | 2024-12-06 | 2024-12-04 |
| Insider sale notice | 144 | 2024-12-04 | - |
| Major company event | 8-K | 2024-12-02 | 2024-12-02 |
| Passive ownership stake (update) | SC 13G/A | 2024-11-14 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-11-14 | - |
| Passive ownership stake | SC 13G | 2024-11-14 | - |
| Quarterly report | 10-Q | 2024-11-12 | 2024-09-30 |
| Major company event | 8-K | 2024-11-12 | 2024-11-12 |
| Passive ownership stake (update) | SC 13G/A | 2024-11-12 | - |
| Passive ownership stake | SC 13G | 2024-11-08 | - |
| Insider trade | 4 | 2024-11-08 | 2024-11-06 |
| Insider trade | 4 | 2024-11-08 | 2024-11-06 |
| Insider sale notice | 144 | 2024-11-06 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-11-04 | - |
| Major company event | 8-K | 2024-10-24 | 2024-10-24 |
| Passive ownership stake | SC 13G | 2024-10-22 | - |
| Insider trade | 4 | 2024-10-04 | 2024-10-02 |